CLIA Certified Molecular Diagnostics & PGD Laboratory
Reprogenetics is a full-service pre-implantation genetic diagnosis (PGD) laboratory based out of Livingston, NJ that has provided embryo diagnostics for couples undergoing in vitro fertilization for more than a decade. Reprogenetics has partnered with Recombine to provide laboratory services and support with patients who have decided to choose Preimplantation Genetic Diagnosis to have a healthy child.
Sample Collection, Stablization & Preparation
DNA Genotek, a subsidiary of OraSure Technologies, Inc., develops products that optimize ease of collection and provide superior samples and proven performance for those requiring high-quality biological samples for nucleic acid testing. High-quality samples that are easily collected enable customers to focus on translating their analysis and testing into significant worldwide advancements in health and science.
Recombine is a clinical genetic testing company. Our goal is to help you make informed medical decisions based on clear and actionable genetic testing results. Our company was started by experts in the fields of fertility, clinical genetics, bioinformatics and computer science brought together with one goal in mind: to improve health outcomes with responsible use of genetic testing.
Recombine's Governing Principles
Kelly Ketterson, M.S.
Chief Executive Officer
Kelly Ketterson serves as the Chief Executive Officer for Recombine. She has had considerable experience growing and managing an emerging genetics company. Ms. Ketterson served as the Director of Operations at Reprogenetics. In her role at Recombine she is responsible for Client Services, Marketing, Sales, Public Relations, Community Relations and Execution. Ms. Ketterson completed a Masters Program in Biomedical Science at the Jones Institute at Eastern Virginia Medical School and is a highly experienced clinical embryologist. She worked under the direction of Dr. Jacques Cohen from 1996-2004 at The Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center performing routine IVF procedures, clinical research trials, and conferences specializing in the continuing education of reproductive endocrinologists, IVF nurses, embryologists, andrologists and administrative staff. Prior to her career in reproductive woman's health, Ms. Ketterson worked for six years as a health care consultant for Buck Consultants, Inc.
Chief Technology Officer
Alexander Bisignano serves as the Chief Technology Officer for Recombine. Alex is a seasoned computer programmer with experience developing bioinformatic applications and providing high-end bioinformatic solutions for molecular genetic data. As the Chief Technology Officer, Alex is responsible for developing and managing the core technology platforms at Recombine. Prior to his work in bioinformatics, Alex worked at Credit Suisse where he was responsible for improving the performance of large internal database systems. Alex received his B.A. in Molecular Biology from Princeton University. He is also a member of Sigma Xi, the Scientific Research Society.
Santiago Munné, Ph.D.
Chief Scientific Officer
Santiago Munné serves as the Chief Scientific Officer for Recombine. Originally from Barcelona, he gained his Ph.D. in genetics from the University of Pittsburgh and joined Dr. Jacques Cohen at Cornell University Medical College New York in 1991. There he developed the first Preimplantation Genetic Diagnosis (PGD) test to detect embryonic numerical chromosome abnormalities such as Down's Syndrome and other abnormalities. From 1995 to 2001, Dr. Munné was director of PGD at the Institute for Reproductive Medicine and Science of Saint Barnabas, where he also developed the first test to detect chromosome translocations in human embryos. Dr. Munné founded Reprogenetics in 2001 and expanded PGD services to Europe, Japan and South America. His team has performed over 10,000 PGD cycles for chromosome abnormalities to improve IVF outcome, more than 1,000 translocations cycles, and nearly 300 PGD procedures for gene defects. Dr. Munné has authored and published over 170 publications, and is a frequent lecturer, both nationally and internationally, on his team's work in the field of Preimplantation Genetics.
Jill Fischer, M.S.
Director of Clinical Genetics
Ms. Fischer serves as the Director of Clinical Genetics for Recombine. Ms. Fischer was the Preimplantation Genetic Diagnosis Program Coordinator and Genetic Counselor for Reprogenetics beginning in 2004. Before Reprogenetics, Ms. Fischer held the same titles at The Institute for Reproductive Medicine and Science (IRMS) at Saint Barnabas Medical Center. Prior to joining IRMS, Ms. Fischer worked at Spectrum Health Genetic Services where she prepared and organized in-house and outreach pediatric genetics clinics, and counseled patients regarding diagnosis, recurrence risks, testing options, test results and follow-up care. From 1993 to 1995, she was a Lecturer and Genetic Counselor at the Eastern Virginia Medical School in Norfolk, Virginia. She received her undergraduate degree in Pre-medicine from Northwestern University in 1991 and a Master of Science degree in Genetic Counseling in 1993 from University of South Carolina.
Neha Kumar, M.S.
Director of Genetics & Marketing
Neha Kumar is Recombine’s Director of Genetics and Marketing. Prior to joining Recombine Neha was an analyst at C1 Consulting, a boutique life sciences consulting firm, where she guided pharmaceutical and biotechnology clients in their marketing decision-making and strategy. In addition to her marketing expertise, Neha brings extensive clinical and research experience in genetics and prenatal diagnosis from her training at the National Human Genome Research Center and Johns Hopkins Hospital. She received her M.S. in Genetic Counseling from Johns Hopkins University and a B.S. in Human Biology from Brown University.
Charlotte Rivera Garcia
Charlotte Rivera Garcia is an Associate Bioinformaticist at Recombine, where she works with mutation database curation and validation sample data analysis. Charlotte also has extensive research experience from her time studying at The University of Pennsylvania. She received her B.S.E in Bioengineering from the University of Pennsylvania and is currently working on her M.S. in Biomedical Engineering from The Grove School of Engineering, City University of New York City College.
As a Web Developer for Recombine, Grant Kot focuses on displaying Recombine’s front end to the user in a clear and cohesive manner. Grant is well versed in computational fluid dynamics and has made several interactive web applications. He received his B.M. in Music from Juilliard.
Dagan Wells, Ph.D.
Dr. Wells has been involved in Preimplantation Genetic Diagnosis (PGD) and the study of human gametes and embryos since 1992. Shortly after obtaining his PhD he was awarded a Medical Research Council Fellowship, during the course of which he successfully developed the first strategy for screening the entire set of chromosomes in single cells using comparative genomic hybridisation (CGH). He stayed on at the college as a Medical Research Council Research Fellow in the Department of Obstetrics & Gynecology until 1999. He worked in the UCL Centre for Preimplantation Genetic Diagnosis from 1999 to 2002 before coming to the United States. In 2000 he joined Reprogenetics where he initiated the there their single gene PGD program, which has grown exponentially since its inception. In 2003, he took a position at Yale University, where he spent four years as an Assistant Professor in the Department of Obstetrics and Gynecology. Dagan and his research team relocated to the Nuffield Department of Obstetrics and Gynaecology at the University of Oxford at the end of 2007, where he is currently an associate professor. The following year he assisted in setting up Reprogenetics-UK where he is a founder and Director. During this period Dagan and his group, in collaboration with Reprogenetics, began clinical trials of CGH applied to human oocytes and blastocysts, which have led to some of the highest IVF pregnancy rates recorded to date. Dagan's work has been recognized with several prizes, including the American Society for Reproductive Medicine General Program Prize (2000) and the publication of more than 80 papers in peer-review journals. Dagan is a Fellow of the Royal Society of Pathologists and serves on the editorial boards of several international medical journals.
Jamie Grifo, M.D.
Dr. Grifo's career in reproductive medicine began in 1988. He has focused his research on Preimplantation Genetic Diagnosis, resulting in the first U.S. baby born following this procedure. Dr. Grifo received his doctorate in biochemistry, and his medical degree, from Case Western Reserve University. He completed residency at the New York Hospital-Cornell Medical Center and fellowship in reproductive endocrinology at Yale University. Board certified in obstetrics and gynecology, and reproductive endocrinology, Dr. Grifo also is accredited in advanced operative laparoscopy and hysteroscopy through the American Association of Gynecologic Laparoscopists. An elected member of Phi Beta Kappa and Alpha Omega Alpha (AOA), Dr. Grifo has received many honors during his career, including several fellowship awards. In 1996, he received the President's Award from RESOLVE. In 1997, Dr. Grifo was named one of the '401 Best Doctors for Women in America' by Good Housekeeping magazine, and has been designated one of the best doctors in New York by New York Magazine yearly since 1996. He has presented several prize papers at the American Society of Reproductive Medicine Dr. Grifo has published more than 135 medical and scientific articles in addition to numerous book chapters, and he speaks frequently at medical-scientific meetings and symposia. He has directed the research efforts at NYU, which has resulted in many improvements in assisted reproduction including nuclear transfer, blastocyst transfer, oocyte freezing and Preimplantation Genetic Diagnosis. He is an active member, and has held office in the American Society for Reproductive Medicine (ASRM) and is a past president of The Society for Assisted Reproduction (SART).
Mark Surrey, M.D.
Co-founder and Medical Director of the Southern California Reproductive Center, Dr. Mark Surrey is a leader in the field of fertility and reproductive medicine, including reproductive surgery and in vitro fertilization (IVF). Dr. Surrey, a reproductive endocrinologist, is board-certified in obstetrics and gynecology. He serves as Associate Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA. He is also Associate Director for Advanced Technologies at the Center for Fertility and Reproductive Medicine at Cedars-Sinai Medical Center. Dr. Surrey is past president of the American Association of Gynecologic Laparoscopists (AAGL), the largest association of minimally invasive gynecologists in the United States, and the leading organization of its kind worldwide. He is also past president of the Pacific Coast Reproductive Society, the premier society of IVF specialists in the western United States. Dr. Surrey is a prolific researcher, authoring numerous publications for leading peer-reviewed journals including Fertility and Sterility and the Journal of Assisted Reproduction and Genetics. Voted one of the 'Top 100 Health Professionals' and listed in 'Best Doctors in America,' Dr. Surrey's ability to help people achieve their fertility goals has made him a physician of choice for patients from all over the world for more than 25 years. Dr. Surrey earned his bachelor's degree from the University of Pittsburgh and his M.D. from George Washington University. Following an internship and residency at UCLA Medical Center, he completed a research Fellowship in Reproductive Endocrinology and an Infertility Fellowship at the University of London, Hammersmith Hospital. He trained in Preimplantation Genetic Diagnosis at the University of London and Monash University, Melbourne.
José A. Horcajadas, Ph.D.
Dr. Horcajadas currently serves as the Chief Scientific Officer at Recombine Europe and Assistant Professor at the University Pablo de Olavide, Sevilla, Spain. He has extensive experience in molecular genetics, microarray facilities and human reproduction research. From 2002-2008, he served as the Molecular Biology Group Leader for the Fundacion IVI, Valencia, Spain, during which time he researched the molecular basis of embryonic implantation and endometrial receptivity. From 2009-2011 he served as Chief Scientific Officer of iGenomix, the Division of Genetics of IVI. Dr. Horcajadas has authored over 40 publications in major scientific journals, as well as 5 books and several chapters more. He has served as the Deputy Coordinator of the 'Endometrium and Endometriosis Interest Group' of ESHRE, a member of the Executive Board of the 'Early Pregnancy Interest Group' of ESHRE, and as an Associate Editor of the journal 'Molecular Human Reproduction.' Nowadays he is the Spanish Representative of Basic Science at ESHRE.
Zsolt Peter Nagy, Ph.D.
Dr. Nagy obtained his MD (1986) and his Ob&Gyn degrees (1996) at the Semmelweis Medical University in Budapest. His PhD was granted at the Free University of Brussels in 1997, where he worked in the team that developed the ICSI procedure. More recently, he has contributed to the development of a highly efficient oocyte cryopreservation procedure that gave bases to establishing the first donor cryobank in USA. He is author of more than 150 publications and book chapters. Dr. Nagy serves on the board of several different societies; as well he is Associate Editor for Human Reproduction and RBMonline. Currently, Dr. Nagy is the Scientific and Laboratory Director at Reproductive Biology Associates, Atlanta, USA.
David I. Hoffman, M.D.
David I. Hoffman, M.D., is subspecialty certified in Reproductive Endocrinology and Infertility, has over 23 years of experience in the diagnosis and treatment of infertility, and has published over 65 abstracts, articles, and book chapters. He joined Doctor Maxson at the Northwest Center for Infertility and Reproductive Endocrinology in 1989. Prior to coming to South Florida he served on the faculty at the University of Southern California in Los Angeles, as Professor in the Department of Obstetrics and Gynecology at Northwestern University in Chicago, Director of the IVF Program at Northwestern Memorial Hospital, and Section Head of the Division of Reproductive Endocrinology and Infertility at Northwestern University Medical School. Currently, in addition to working at our Fort Lauderdale-area offices as an infertility specialist, David I. Hoffman, M.D., also serves as a Voluntary Associate Professor in the Department of Obstetrics and Gynecology at the University of Miami, School of Medicine.